FDA rejects advice, nixes OTC status for morning-after pill

The FDA, citing safety issues, decided the Plan B emergency contraception pill will not be allowed to be sold on an over-the-counter basis. Although the agency's own panel of experts recommended OTC status for Barr Pharmaceuticals' contraceptive drug, FDA officials decided the case for freer distribution had not been made. The agency suggested it would revisit the issue if Barr could prove the pill was safe for younger women or provide a plan that would protect against the pill's availability to underage girls.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN